patient
transfusion-dependent thalassemia
home intravenous desferrioxamine
DFX
treatment
implanted system
poor compliance
nightly subcutaneous therapy
accidental
malfunctioning
infusion
patient
administered
toxic dosage
drug
renal insufficiency
progressive
deterioration
symptoms
laboratory values
adequate
medical treatment
decision
haemodialytical therapy
drug
therapy
reduce
nephrotoxicity
results
haemodialysis
therapy
cases
progressive
acute renal failure
desferrioxamine
